Monitoring of laying capacity, immunoglobulin Y concentration, and antibody titer development in chickens immunized with ricin and botulinum toxins over a two-year period

Poultry Science

Volumn 88, Issue 2, 2009, Pages 281-290

  Pauly, D ^a   Dorner, M ^a   Zhang, X ^b   Hlinak, A ^c   Dorner, B ^a   Schade, R ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Abteilung T2 Virologie   (Germany)

Author keywords

Botulinum neurotoxin; Circaseptan rhythm; Immunoglobulin y content; Laying capacity; Ricin

Indexed keywords

ANIMALIA; CLOSTRIDIUM BOTULINUM; GALLUS GALLUS;

BOTULINUM TOXIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN Y; IMMUNOTOXIN; RICIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CHICKEN; EGG; EGG LAYING; FEMALE; IMMUNIZATION; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; BOTULINUM TOXINS; CHICKENS; EGGS; FEMALE; IMMUNIZATION; IMMUNOGLOBULINS; IMMUNOTOXINS; OVIPOSITION; RICIN;

EID: 63249105438     PISSN: 00325791     EISSN: 15253171     Source Type: Journal    
DOI: 10.3382/ps.2008-00323     Document Type: Article

References (50)

1. Abrahamsson, P., and R. Tauson. 1998. Performance and egg quality of laying hens in an aviary system. J. Appl. Poult. Res. 7: 225-232.
2. Altschuh, D., G. Hennache, and M. H. van Regenmortel. 1984. Determination of IgG and IgM levels in serum by rocket immunoelectrophoresis using yolk antibodies from immunized chickens. J. Immunol. Methods 69: 1-7.
3. Arnon, S. S., R. Schechter, T. V. Inglesby, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, J. Hauer, M. Layton, S. Lillibridge, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, D. L. Swerdlow, and K. Tonat. 2001. Botulinum toxin as a biological weapon: Medical and public health management. JAMA 285: 1059-1070.
4. Audi, J., M. Belson, M. Patel, J. Schier, and J. Osterloh. 2005. Ricin poisoning: a comprehensive review. JAMA 294: 2342-2351.
5. Behring, E. 1900. Allgemeine Therapie der Infectionskrankheiten. [II. Theil]. Beiträge zur experimentellen Therapie. Urban & Schwarzenberg, Berlin, Germany.
6. Bengtson, I. A. 1924. Studies on organisms concerned as causative factors in botulism. Hyg. Lab. Bull. 136: 1-97.
7. Bizhanov, G., and G. Vyshniauskis. 2000. A comparison of three methods for extracting IgY from the egg yolk of hens immunized with Sendai virus. Vet. Res. Commun. 24: 103-113.
8. Bollen, L. S., and J. Hau. 1999. Freund's complete adjuvant has a negative impact on egg laying frequency in immunised chickens. In Vivo 13: 107-108.
9. Bradberry, S. M., K. J. Dickers, P. Rice, G. D. Griffiths, and J. A. Vale. 2003. Ricin poisoning. Toxicol. Rev. 22: 65-70.
10. Carlander, D., M. Wilhelmson, and A. Larsson. 2001. Limited day to day variation of IgY levels in eggs from individual laying hens. Food Agric. Immunol. 13: 87-92.
11. Carlander, D., M. Wilhelmson, and A. Larsson. 2003. Immunoglobulin Y levels in egg yolk from three chicken genotypes. Food Agric. Immunol. 15: 35-40.
12. Cornelissen, G., T. K. Breus, C. Bingham, R. Zaslavskaya, M. Varshitsky, B. Mirsky, M. Teibloom, B. Tarquini, E. Bakken, and F. Halberg. 1993. Beyond circadian chronorisk: Worldwide circaseptan-circasemiseptan patterns of myocardial infarctions, other vascular events, and emergencies. Chronobiologia 20: 87-115.
13. De Ceuninck, F., P. Pastoureau, S. Agnellet, J. Bonnet, and P. M. Vanhoutte. 2001. Development of an enzyme-linked immunoassay for the quantification of YKL-40 (cartilage gp-39) in guinea pig serum using hen egg yolk antibodies. J. Immunol. Methods 252: 153-161.
14. De Meulenaer, B., and A. Huyghebaert. 2001. Isolation and purification of chicken egg yolk immunoglobulins: A review. Food Agric. Immunol. 13: 275-288.
15. Erhard, M. H., P. Schmidt, A. Hofmann, J. Bergmann, P. Mittermeier, P. Kaufmann, K. H. Wiesmüller, W. G. Bessler, and U. Lösch. 1997. The lipopeptide Pam3Cys-Ser-(Lys)4: an alternative adjuvant to Freund's adjuvant for the immunisation of chicken to produce egg yolk antibodies. Altern. Lab. Anim. 25: 173-181.
16. Gassmann, M., P. Thömmes, T. Weiser, and U. Hübscher. 1990. Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. FASEB J. 4: 2528-2532.
17. Halberg, F., G. Cornelissen, Z. Wang, C. Wan, W. Ulmer, G. Katinas, R. Singh, R. K. Singh, R. K. Singh, B. D. Gupta, R. B. Singh, A. Kumar, E. Kanabrocki, R. B. Sothern, G. Rao, M. L. Bhatt, M. Srivastava, G. Rai, S. Singh, A. K. Pati, P. Nath, F. Halberg, J. Halberg, O. Schwartzkopff, and E. Bakken, and Governor Shri Vishnu Kant Shastri. 2003. Chronomics: Circadian and circaseptan timing of radiotherapy, drugs, calories, perhaps nutriceuticals and beyond. J. Exp. Ther. Oncol. 3: 223-260.
18. Hassl, A., and H. Aspock. 1988. Purification of egg yolk immunoglobulins. A two-step procedure using hydrophobic interaction chromatography and gel filtration. J. Immunol. Methods 110: 225-228.
19. Haus, E., and M. H. Smolensky. 1999. Biologic rhythms in the immune system. Chronobiol. Int. 16: 581-622.
20. Hendrix Genetics. 2006. ISA Product Performance. Hendrix Genetics, Boxmeer, the Netherlands.
21. Kink, J. A., and J. A. Williams. 1998. Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection. Infect. Immun. 66: 2018-2025.
22. Kitaguchi, K., M. Minoura, M. Noritake, M. Mizutani, K. Kinoshita, F. Horio, and A. Murai. 2008. Determination of immunoglobulin Y concentration in yolk extract prepared by water dilution method: Comparisons among three strains of chickens. Jpn. Poult. Sci. 45: 82-87.
23. Kitasato, S. 1891. Experimentelle Untersuchungen über das Tetanusgift. Z. Hyg. Infektionskr. 10: 267-305.
24. Klemperer, F. 1893. Ueber natürliche Immunität und ihre Verwerthung für die Immunisirungstherapie. Naunyn Schmiedebergs Arch. Pharmacol. 31: 356-382.
25. Kollberg, H., D. Carlander, H. Olesen, P. E. Wejaker, M. Johannesson, and A. Larsson. 2003. Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: A phase I feasibility study. Pediatr. Pulmonol. 35: 433-440.
26. Kovacs-Nolan, J., and Y. Mine. 2005. Passive immunization through avian egg antibodies. Food Biotechnol. 18: 39-62.
27. Kowalczyk, K., J. Daiss, J. Halpern, and T. F. Roth. 1985. Quantitation of maternal-fetal IgG transport in the chicken. Immunology 54: 755-762.
28. Labrecque, G., J. P. Bureau, and A. E. Reinberg. 1995. Biological rhythms in the inflammatory response and in the effects of nonsteroidal anti-inflammatory drugs. Pharmacol. Ther. 66: 285-300.
29. Larsson, A., R. M. Bålöw, T. L. Lindahl, and P. O. Forsberg. 1993. Chicken antibodies: Taking advantage of evolution-A review. Poult. Sci. 72: 1807-1812.
30. LeClaire, R. D., R. E. Hunt, and S. Bavari. 2002. Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination. Infect. Immun. 70: 2278-2281.
31. Lemley, P. V., B. S. Thalley, and D. C. Stafford. 1995. Prophylactic and therapeutic efficacy of an avian antitoxin in ricin intoxication. Ther. Immunol. 2: 59-66.
32. Li, X., T. Nakano, H. H. Sunwoo, B. H. Paek, H. S. Chae, and J. S. Sim. 1998. Effects of egg and yolk weights on yolk antibody (IgY) production in laying chickens. Poult. Sci. 77: 266-270.
33. Lohmann Tierzucht GmbH. 2008.Lohmann LSL Layer. Lohmann Tierzucht, Cuxhaven, Germany.
34. Lord, M. J., N. A. Jolliffe, C. J. Marsden, C. S. Pateman, D. C. Smith, R. A. Spooner, P. D. Watson, and L. M. Roberts. 2003. Ricin. Mechanisms of cytotoxicity. Toxicol. Rev. 22: 53-64.
35. Maya Devi, C., M. Vasantha Bai, and L. K. Krishnan. 2002. Development of viper-venom antibodies in chicken egg yolk and assay of their antigen binding capacity. Toxicon 40: 857-861.
36. McGuinness, C. R., and N. J. Mantis. 2006. Characterization of a novel high-affinity monoclonal immunoglobulin G antibody against the ricin B subunit. Infect. Immun. 74: 3463-3470.
37. Mieβner, and Rewald. 1909. Die Konglutination der roten Blutkör-perchen durch Rizinussamen. Z. Immunitätsforsch. Exp. Ther. 2: 323-349.
38. Mine, Y., and J. Kovacs-Nolan. 2002. Chicken egg yolk antibodies as therapeutics in enteric infectious disease: A review. J. Med. Food 5: 159-169.
39. Motoi, Y., K. Sato, H. Hatta, K. Morimoto, S. Inoue, and A. Yamada. 2005. Production of rabies neutralizing antibody in hen's eggs using a part of the G protein expressed in Escherichia coli. Vaccine 23: 3026-3032.
40. Olsnes, S., E. Saltvedt, and A. Pihl. 1974. Isolation and comparison of galactose-binding lectins from Abrus precatorius and Ricinus communis. J. Biol. Chem. 249: 803-810.
41. Pei, J., and E. W. Collisson. 2005. Specific antibody secreting cells from chickens can be detected by three days and memory B cells by three weeks post-infection with the avian respiratory coronavirus. Dev. Comp. Immunol. 29: 153-160.
42. Polson, A., M. B. von Wechmar, and M. H. van Regenmortel. 1980. Isolation of viral IgY antibodies from yolks of immunized hens. Immunol. Commun. 9: 475-493.
43. Rosol, T. J., C. L. Steinmeyer, L. K. McCauley, J. I. Merryman, J. R. Werkmeister, A. Grone, M. T. Weckmann, D. E. Swayne, and C. C. Capen. 1993. Studies on chicken polyclonal anti-peptide antibodies specific for parathyroid hormone-related protein (1-36). Vet. Immunol. Immunopathol. 35: 321-337.
44. Schade, R., I. Behn, M. Erhard, A. Hlinak, and C. Staak. 2001. Chicken egg yolk antibodies, production and application: IgY-Technology. Springer, Berlin, Germany.
45. Schade, R., E. G. Calzado, R. Sarmiento, P. A. Chacana, J. Porankiewicz-Asplund, and H. R. Terzolo. 2005. Chicken egg yolk antibodies (IgY-technology): A review of progress in production and use in research and human and veterinary medicine. Altern. Lab. Anim. 33: 129-154.
46. Simpson, L. L. 2004. Identification of the major steps in botulinum toxin action. Annu. Rev. Pharmacol. Toxicol. 44: 167-193.
47. Stålberg, J., and A. Larsson. 2001. Extraction of IgY from egg yolk using a novel aqueous two-phase system and comparison with other extraction methods. Ups. J. Med. Sci. 106: 99-110.
48. van Ermengem, E. 1897. Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus. Z. Hyg. Infektionskr. 26: 1-56.
49. Zhang, W. W. 2003. The use of gene-specific IgY antibodies for drug target discovery. Drug Discov. Today 8: 364-371.
50. Zuther, P., and B. Lemmer. 2004. Chronos-Fit, http://www.ma.uniheidelberg.de/inst/phar/forschungLemmer.html. Accessed Dec. 2008.